FDA inspection
Teva Branded Pharmaceutical Products R & D, Inc.: FDA inspection ending Feb 28, 2003
FDA inspection 261759 · Official Action Indicated (OAI) · Miami, FL
Key facts
| Inspection ID | 261759 |
|---|---|
| Firm | Teva Branded Pharmaceutical Products R & D, Inc. |
| FEI number | 1000140211 |
| Address | 74 NW 176th St |
| City | Miami |
| State | FL |
| ZIP | 33169-5043 |
| Fiscal year | 2003 |
| Inspection end date | Feb 28, 2003 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data